Nebracetam

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by CheMoBot (talk | contribs) at 22:05, 27 February 2017 (Updating {{infobox_drug}} (changes to verified and watched fields - updated 'ChEMBL_Ref', 'Verifiedfields', 'Watchedfields') per Chem/infobox_drug validation (report errors or [[user talk:Che...). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Nebracetam
Clinical data
ATC code
  • none
Legal status
Legal status
  • US: Unscheduled Not FDA approved
Identifiers
  • (RS)-4-(Aminomethyl)-1-benzylpyrrolidin-2-one
CAS Number
PubChem CID
ChemSpider
UNII
ChEMBL
Chemical and physical data
FormulaC12H16N2O
Molar mass204.268 g/mol g·mol−1
3D model (JSmol)
ChiralityRacemic mixture
  • O=C2N(Cc1ccccc1)CC(C2)CN
  • InChI=1S/C12H16N2O/c13-7-11-6-12(15)14(9-11)8-10-4-2-1-3-5-10/h1-5,11H,6-9,13H2 checkY
  • Key:LCAFGJGYCUMTGS-UHFFFAOYSA-N checkY
 ☒NcheckY (what is this?)  (verify)

Nebracetam is an investigational drug of the racetam family that is a M1 acetylcholine receptor agonist in rats.[1] Its effects in humans have not been studied.

See also

References

  1. ^ Takeo, S.; Hayashi, H.; Miyake, K.; Takagi, K.; Tadokoro, M.; Takagi, N.; Oshikawa, S. (1997). "Effects of delayed treatment with nebracetam on neurotransmitters in brain regions after microsphere embolism in rats". British Journal of Pharmacology. 121 (3): 477–484. doi:10.1038/sj.bjp.0701161. PMC 1564714. PMID 9179389.


Stub icon

This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it.

Retrieved from "https://en.wikipedia.org/w/index.php?title=Nebracetam&oldid=767777864"